## Abstract Three hundred thirtyβsix medical personnel from hemodialysis centers were treated with three doses, 20 ΞΌg each, of the Merck hepatitis B vaccine (at 0, 1, and 6 months). Within 1 month after the first injection, 41% converted to antiβHBs positivity; after the second injection the conver
Evaluation of a reduced dose of hepatitis B vaccine administered intradermally
β Scribed by Gert Zoulek; Bernd Lorbeer; Wolfgang Jilg; Friedrich Deinhardt
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 316 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Immunologic markers associated with hepatitis B virus (HBV) infection (HBsAg, antiβHBs, HBeAg, antiβHBe, antiβHBc, antiβΞ΄) were tested by radioimmunoassay of serum from chronic hepatitis patients. The corresponding liver biopsy samples were examined for the presence of HBsAg, HBcAg, and
The immunogenicity of a 5-micrograms dose of vaccine (H-B-Vax, MSD) was evaluated in 50 young adults (17-19 years). Results were compared to our previous studies using similarly prepared vaccines using 20 micrograms and 10 micrograms per dose with the same trial protocol in a comparable population.
Nineteen healthy young adults were vaccinated with plasma-derived hepatitis B vaccine at months 0, 1, and 12, and their immune responses were compared to those of a similar group of 20 vaccinees immunized at months 0, 1, and 6. Late booster injections at 12 months produced nearly fivefold higher geo
The safety of a plasma-derived hepatitis-B vaccine inactivated by two heating steps (90 sec at 103 "C followed by 10 hr pasteurization at 65 "C) was validated in chimpanzees; 1 O3 chimpanzee-infectious doses (CID,,) of hepatitis-B virus (HBV), subjected to the purification steps during production of